Intrinza

by Procter & Gamble Pharmaceuticals

Heard in 2 episodes across 2 shows since Sep 2026

Intrinsa was a 300 microgram-per-24-hour testosterone transdermal patch developed for testosterone replacement in surgically induced menopause, particularly to treat hypoactive sexual desire disorder in women receiving concomitant estrogen therapy. It was developed and marketed in Europe by Procter & Gamble Pharmaceuticals; its European authorization was later withdrawn and it is no longer generally marketed.